Data / Form D filings / HAWKHILL THERAPEUTICS Ltd
HAWKHILL THERAPEUTICS Ltd: Form D filings
HAWKHILL THERAPEUTICS Ltd, a biotechnology company in Dundee, Scotland, United Kingdom, filed 2 Form D notices with the SEC in 2026. The latest, on September 29, 2026, reports $290,530 sold of a $290,530 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- LIFE SCIENCES INNOVATION HUB 5 JAMES LINDSAY PLACE, Dundee, Scotland, United Kingdom, DD1 5
- Phone
- (555) 555-5555
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- United Kingdom
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2140690
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Amendment | $290,530 | $290,530 | 1 | Apr 7, 2026 | sec.gov | |
| Jun 23, 2026 | New notice | $192,569 | $192,569 | 1 | Apr 7, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Andrew Woodland | Executive Officer, Director | |
| Antoine Boulanger | Director | |
| Mary Canning | Director | |
| Francisca Peixoto | Director | |
| Timothy Jason Sparey | Director |
Every Form D from the week of Sep 28, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what HAWKHILL THERAPEUTICS Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.